Hydrocodone, Urine
Bacterial Vaginosis Pathogens by Molecular Method
Achalasia
Protoporphyrin, Free, Blood
Cancer Antigen (CA) 125
Group B Streptococcus (GBS), Molecular Detection, PCR
WIPF1 Gene Mutation Analysis
Dopamine beta-hydroxylase (DBH) Genetic Variations
Pregnancy Associated Plasma Protein-A (PAPP-A)
Complement Component C3A
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Turnaround Time
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...